Journal of Biomedical Science

Table 5 Biosafety assessment of H7N9 CVVs

From: Development of high-growth influenza H7N9 prepandemic candidate vaccine viruses in suspension MDCK cells

CVVs	CELD₅₀^a
Wild-type H7N9 (A/Taiwan/1/2017)	10^–1.17 TCID₅₀
NHRI-RG3	> 10^6.65 TCID₅₀
NHRI-RG4	> 10^7.04 TCID₅₀
NHRI-RG5	> 10^7.65 TCID₅₀
NHRI-RG6	> 10^6.65 TCID₅₀

Note: ^aCELD₅₀: median chicken embryo lethal dose; expressed as median tissue culture infectious dose (TCID₅₀)

Back to article page

ISSN: 1423-0127

Contact us

Submission enquiries: Access here and click Contact Us
General enquiries: info@biomedcentral.com